Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Wound Care

PUBLISHER: Grand View Research | PRODUCT CODE: 1474934

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1474934

IV Dressing Market Size, Share & Trends Analysis Report By Type (Transparent, Translucent), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

IV Dressing Market Growth & Trends:

The global IV dressing market size is anticipated to reach USD 1.21 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 5.50% from 2024 to 2030. Increasing cases of blood infections, such as CLABSI and CRBSI, and a rising number of hospital admissions are likely to boost market demand. Also, the rising geriatric population and increasing prevalence of chronic disorders are factors contributing to market growth. For instance, according to the WHO, between 2015 and 2050, the proportion of geriatric population is expected to double from 12% to 22%, making old age a significant risk factor for developing chronic disorders. A rise in awareness and adoption of IV therapy for treating various chronic diseases including cancer is anticipated to drive market growth. Various players are launching novel IV therapies.

For instance, in January 2023, Glenmark Pharmaceuticals Ltd. launched the IV infection formulation AKYNZEO IV in India to prevent chemotherapy-induced vomiting and nausea. Strategic initiatives undertaken by top players, such as acquisitions, are expected to contribute to market growth. For instance, in September 2022, B. Braun Medical Inc. acquired catheter securement products from Starboard Medical. This initiative was anticipated to improve patient care and extend the company's IV therapy offering including IV dressing. Furthermore, geographical expansion activities by key players are projected to boost market growth. For instance, in January 2022, Smith+Nephew inaugurated a new commercial hub to increase the company's product offerings in the Nordic region.

IV Dressing Market Report Highlights:

  • The transparent product segment accounted for the largest market share in 2023 and is expected to grow at the fastest CAGR of 5.71% from 2024 to 2030
  • This is owing to the introduction of a novel transparent film dressing with a chlorhexidine gluconate-impregnated gelpatch to offer ongoing disinfection of the site throughout the duration of the catheter
  • The hospitals end-use segment held the largest revenue share of 45.39% in 2023 owing to the high healthcare investments, a rise in the number of hospitalizations, and incidences of infectious & chronic diseases
  • North America captured the largest revenue share of 45.46% in 2023. This is owing to the well-developed healthcare infrastructure, high geriatric population, and rise in the awareness & adoption of IV therapies
Show more
Product Code: GVR-4-68040-247-2

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
      • 1.6.1.1. Commodity flow analysis (Model 1)
      • 1.6.1.2. Approach 1: Commodity flow approach
      • 1.6.1.3. Volume price analysis (Model 2)
      • 1.6.1.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. I.V. Dressing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing cases of blood infections such as CLABSI and CRBSI
      • 3.2.1.2. Increasing hospital admission
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Complications associated with I.V. dressing
  • 3.3. I.V. Dressing Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. I.V. Dressing: Type Estimates & Trend Analysis

  • 4.1. I.V. Dressing Market: Type Movement Analysis
    • 4.1.1. Transparent
      • 4.1.1.1. Transparent market estimates and forecast, 2018 - 2030
    • 4.1.2. Translucent
      • 4.1.2.1. Translucent market estimates and forecast, 2018 - 2030

Chapter 5. I.V. Dressing: End-use Estimates & Trend Analysis

  • 5.1. I.V. Dressing Market: End-use Movement Analysis
    • 5.1.1. Hospitals
      • 5.1.1.1. Hospitals market estimates and forecast 2018 to 2030, (USD million)
    • 5.1.2. Clinics
      • 5.1.2.1. Clinics Institutes market estimates and forecast 2018 to 2030, (USD Million)
    • 5.1.3. Others
      • 5.1.3.1. Others market estimates and forecast 2018 to 2030, (USD million)

Chapter 6. I.V. Dressing Market: Regional Estimates & Trend Analysis

  • 6.1. Global Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Target Disease Prevalence
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Target Disease Prevalence
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.3. Europe
    • 6.3.1. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Target Disease Prevalence
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Target Disease Prevalence
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Target Disease Prevalence
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Target Disease Prevalence
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Target Disease Prevalence
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Target Disease Prevalence
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Target Disease Prevalence
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Target Disease Prevalence
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.2. China
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.3. Japan
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Target Disease Prevalence
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Target Disease Prevalence
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Target Disease Prevalence
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.5. Latin America
    • 6.5.1. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 6.6. MEA
    • 6.6.1. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.3. South Africa
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2022
    • 7.3.4. 3M
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. RICHARDSON HEALTHCARE, INC.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MEDLINE INDUSTRIES
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. SMITH & NEPHEW
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. CARDINAL HEALTH
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. CONVATEC GROUP PLC
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. PAUL HARTMANN AG
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. LOHMANN & RAUSCHER (L&R)
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. MCKESSON CORPORATION
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. MOLNLYCKE HEALTH CARE AB
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. DERMARITE INDUSTRIES, LLC
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. DEROYAL INDUSTRIES, INC.
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. BSN MEDICAL
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. DYNAREX CORPORATION.
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Product benchmarking
      • 7.3.17.4. Strategic initiatives
    • 7.3.18. KOMAL HEALTH CARE PVT. LTD.
      • 7.3.18.1. Company overview
      • 7.3.18.2. Financial performance
      • 7.3.18.3. Product benchmarking
      • 7.3.18.4. Strategic initiatives
    • 7.3.19. SENTRY MEDICAL
      • 7.3.19.1. Company overview
      • 7.3.19.2. Financial performance
      • 7.3.19.3. Product benchmarking
      • 7.3.19.4. Strategic initiatives
    • 7.3.20. SHANDONG DERMCOSY MEDICAL CO.,LTD.
      • 7.3.20.1. Company overview
      • 7.3.20.2. Financial performance
      • 7.3.20.3. Product benchmarking
      • 7.3.20.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-247-2

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global I.V. Dressing Market, By Region 2018 - 2030 (USD Million)
  • Table 4. Global I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 5. Global I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 6. North America I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 8. North America I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9. U.S. I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 10. U.S. I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11. Canada I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 12. Canada I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13. Europe I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 14. Europe I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 15. Europe I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16. UK I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 17. UK I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18. Germany I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 19. Germany I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20. France I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 21. France I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22. Italy I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 23. Italy I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24. Spain I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 25. Spain I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26. Denmark I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 27. Denmark I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28. Sweden I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 29. Sweden I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30. Norway I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 31. Norway I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35. Japan I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 36. Japan I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37. China I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 38. China I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39. India I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 40. India I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. Australia I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 42. Australia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43. Thailand I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 44. Thailand I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45. South Korea I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 46. South Korea I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47. Latin America I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 48. Latin America I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 49. Latin America I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50. Brazil I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 51. Brazil I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52. Mexico I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 53. Mexico I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54. Argentina I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 55. Argentina I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 56. MEA I.V. Dressing Market, By Country, 2018 - 2030 (USD Million)
  • Table 57. MEA I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 58. MEA I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59. South Africa I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 60. South Africa I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63. UAE I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 64. UAE I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65. Kuwait I.V. Dressing Market, By Type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait Arabia I.V. Dressing Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 I.V. Dressing market: Market snapshot
  • Fig. 9 I.V. Dressing market: Market segmentation
  • Fig. 10 I.V. Dressing market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 I.V. Dressing market driver impact
  • Fig. 16 I.V. Dressing market restraint impact
  • Fig. 17 I.V. Dressing market porter's five forces analysis
  • Fig. 18 I.V. Dressing market PESTEL analysis
  • Fig. 19 I.V. Dressing market: Type movement Analysis
  • Fig. 20 I.V dressing market: type outlook and key takeaways
  • Fig. 21 Transparent market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Translucent market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 I.V. dressing market: End use movement Analysis
  • Fig. 24 I.V. dressing market: End use outlook and key takeaways
  • Fig. 25 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global I.V. Dressing market: Regional movement analysis
  • Fig. 29 Global I.V. Dressing market: Regional outlook and key takeaways
  • Fig. 30 Global market share, by region
  • Fig. 31 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!